D S Anson

2.1k citations

35 papers · 1.9k · h-index 23

Impact in

Hematology top 2%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
Physiology top 2%
- Lysosomal Storage Disorders Research

Papers in

Molecular Biology 21
- RNA Interference and Gene Delivery 5
- CRISPR and Genetic Engineering 5
- Glycosylation and Glycoproteins Research 4
- Cancer-related gene regulation 4
Genetics 15
- Virus-based gene therapy research 14

Co-authors: John J. Hopwood (12 shared papers)Julie Bielicki (8 shared papers)G.G. Brownlee (4 shared papers)C. Phillip Morris (4 shared papers)K.H. Andy Choo (2 shared papers)F. Giannelli (2 shared papers)Peter R. Clements (2 shared papers)Peter J. Wilson (2 shared papers)
Journals: Biochemical Journal (6 papers)The Journal of Gene Medicine (3 papers)Human Gene Therapy (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (2 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

D S Anson

35 papers receiving 1.7k citations

Peers

Countries citing papers authored by D S Anson

Since Specialization

Citations

This map shows the geographic impact of D S Anson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D S Anson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D S Anson more than expected).

Fields of papers citing papers by D S Anson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D S Anson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D S Anson. The network helps show where D S Anson may publish in the future.

Co-authors

The 25 scholars most cited alongside D S Anson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D S Anson Line = papers co-authored together D S Anson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The gene structure of human anti‐haemophilic factor IX. The EMBO Journal ·D S Anson, K.H. Andy Choo, D. Jasper G. Rees, F. Giannelli, Keith G. Gould, Joyce A. Huddleston, G.G. Brownlee	1984	326
2	Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proceedings of the National Academy of Sciences ·Peter J. Wilson, C. Phillip Morris, D S Anson, Teresa Occhiodoro, Julie Bielicki, Peter R. Clements, John J. Hopwood	1990	236
3	Human alpha-L-iduronidase: cDNA isolation and expression. Proceedings of the National Academy of Sciences ·Hamish S. Scott, D S Anson, Annette Orsborn, Paul V. Nelson, Peter R. Clements, C. Phillip Morris, John J. Hopwood	1991	132
4	Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms Nucleic Acids Research ·Peter R. Winship, D S Anson, C. R. Rizza, George G. Brownlee	1984	121
5	Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. Journal of Clinical Investigation ·Allison C. Crawley, Doug A. Brooks, Vivienne Muller, B A Petersen, Elizabeth Isaac, Julie Bielicki, Barbara King, Christine D Boulter, Alison Moore, N.L. Fazzalari, D S Anson, Sharon Byers, John J. Hopwood	1996	119
6	CHARACTERISATION AND USE OF AN INTRAGENIC POLYMORPHIC MARKER FOR DETECTION OF CARRIERS OF HAEMOPHILIA B (FACTOR IX DEFICIENCY) The Lancet ·F. Giannelli, K.H. Andy Choo, Peter R. Winship, C. R. Rizza, D S Anson, Dai G., Nicolas Ferrari, G.G. Brownlee	1984	109
7	Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells Nature ·D S Anson, D. E. G. Austen, G.G. Brownlee	1985	82
8	Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase Biochemical Journal ·D S Anson, Jacqueline Taylor, Julie Bielicki, G. S. Harper, C Peters, G J Gibson, John J. Hopwood	1992	65
9	Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme Biochemical Journal ·Julie Bielicki, John J. Hopwood, Peter J. Wilson, D S Anson	1993	60
10	Recombinant α-l-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts Biochemical Journal ·E G Unger, J.L. Durrant, D S Anson, John J. Hopwood	1994	55
11	Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length Respiratory Research ·Patricia Cmielewski, D S Anson, David Parsons	2010	46
12	Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production The Journal of Gene Medicine ·Rachel Koldej, Patricia Cmielewski, Alice G. Stocker, David Parsons, D S Anson	2005	42
13	Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Proceedings of the National Academy of Sciences ·LJ Fairbairn, L. S. Lashford, Elaine Spooncer, R. H. McDermott, G. Lebens, Janet E. Arrand, J. R. Arrand, Ilaria Bellantuono, Richard C. L. Holt, C. E. Hatton, Alan Cooper, G. T. N. Besley, J. E. Wraith, D S Anson, John J. Hopwood, Tim Dexter	1996	38
14	Correction of Mucopolysaccharidosis Type I Fibroblasts by Retroviral-Mediated Transfer of the Human α- l -Iduronidase Gene Human Gene Therapy ·D S Anson, Julie Bielicki, John J. Hopwood	1992	36
15	Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase Biochemical Journal ·Julie Bielicki, Maria Fuller, X H Guo, C. Phillip Morris, J J Hopewood, D S Anson	1995	35
16	Rational development of a HIV‐1 gene therapy vector The Journal of Gene Medicine ·D S Anson, Maria Fuller	2003	33
17	Lentivirus-mediated gene transfer to the rat, ovine and human cornea Gene Therapy ·Douglas G Parker, C. Kaufmann, Helen M. Brereton, D S Anson, L Francis-Staite, Claire F. Jessup, Khiya Marshall, C Tan, Rachel Koldej, Douglas J. Coster, (unknown)	2007	32
18	Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein Biochemical Journal ·Doug A. Brooks, D A Robertson, Colleen Bindloss, Tom Litjens, D S Anson, C Peters, C. Phillip Morris, John J. Hopwood	1995	31
19	Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII Molecular Genetics and Metabolism ·Carmen E. Macsai, Ainslie L.K. Derrick‐Roberts, Xiaodan Ding, Krystyna H. Zarrinkalam, Chantelle McIntyre, Paul Anderson, D S Anson, Sharon Byers	2012	28
20	Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. Journal of Clinical Investigation ·R. James Matthews, D S Anson, I R Peake, A L Bloom	1987	27

About D S Anson

D S Anson is a scholar working on Molecular Biology, Genetics, Physiology, Hematology and Organic Chemistry, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Lysosomal Storage Disorders Research (12 papers), Hemophilia Treatment and Research (6 papers), RNA Interference and Gene Delivery (5 papers), CRISPR and Genetic Engineering (5 papers), Glycosylation and Glycoproteins Research (4 papers), Cancer-related gene regulation (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). The work is most often cited by research in Hematology (470 citations), Physiology (723 citations), Genetics (189 citations), Genetics (396 citations) and Cell Biology (210 citations). D S Anson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include John J. Hopwood, Julie Bielicki, G.G. Brownlee, C. Phillip Morris, K.H. Andy Choo, F. Giannelli, Peter R. Clements, Peter J. Wilson, Peter R. Winship and D. Jasper G. Rees. Their work appears in journals such as Biochemical Journal, The Journal of Gene Medicine, Human Gene Therapy, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D S Anson

Impact in

Papers in i

In The Last Decade

D S Anson

Peers

Countries citing papers authored by D S Anson

Fields of papers citing papers by D S Anson

All Works

About D S Anson

Explore authors with similar magnitude of impact

Papers in